Pharmaceutical-Grade Peptides. When nature meets science.
Primara supplies verified B2B partners across North America, Latin America, and the Caribbean with high-purity GLP-1 agonists and peptide therapies. Every batch is GMP-manufactured, HPLC-verified, and fully documented.
Pharmaceutical-Grade Catalog & Delivery Systems
Every compound is manufactured under strict GMP controls and shipped with lot-level Certificates of Analysis.
Semaglutide, Tirzepatide, Retatrutide, Liraglutide, and Teduglutide in standardized multi-dose formats.
High-purity BPC-157, Ipamorelin, CJC-1295, and therapeutic peptide compounds.
Lyophilized powder vials, liquid multi-dose vials, and custom pre-filled auto-injector pens.
Uncompromising Quality & Full Traceability
Comprehensive analytical testing, process controls, and chain-of-custody documentation accompany every shipment.
Formulated under strict US Good Manufacturing Practice standards with validated process controls.
HPLC purity assay (≥ 99%), mass spectrometry identity, and endotoxin testing verified prior to dispatch.
Unique PHS-LOT and PHS-COA references connect every single vial directly to its analytical batch records.
Temperature-monitored storage and climate-controlled packaging ensure compound stability from facility to partner.
Regional Distribution with Unifying Quality Standards
Delivering consistent regulatory documentation, cold-chain integrity, and dedicated partner support across three key geographies.
Domestic distribution featuring expedited fulfillment, US batch COAs, and complete compliance documentation.
Tailored compliance, bilingual documentation, and dedicated distribution support across LATAM markets.
Cold-chain logistics to clinical, pharmacy, and wholesale distribution partners across the region.
Answers before you apply
Straight answers on quality, shipping, product selection, and partner support.
Primara is a B2B pharmaceutical-grade peptide distribution platform for verified clinics, pharmacies, wholesalers, and authorized partners. We supply GMP-manufactured compounds with lot-level documentation, not retail or direct-to-consumer sales.
Yes. Every lot is analytically verified before dispatch, including HPLC purity (≥ 99%), identity confirmation, and endotoxin testing where applicable. Each shipment is tied to a Certificate of Analysis via PHS-LOT and PHS-COA references.
Products are manufactured in the United States under GMP controls and fulfilled with cold-chain packaging. We distribute to verified partners across the US, Latin America, and the Caribbean.
Most US orders are processed within 1-2 business days after confirmation. Domestic delivery is typically expedited; international and regional shipments depend on destination, cold-chain routing, and any required import documentation.
Variants reflect strength, pack quantity, and delivery format, such as lyophilized vials, liquid multi-dose vials, or auto-injector pens. Select the option that matches your ordering and handling requirements in the partner catalog.
Returns are evaluated case by case for transit damage, shipment errors, or documented lot-quality concerns. Notify us within five business days of delivery for shipping issues. Read the full return policy.
Email support@primarahealthsciences.com for orders and documentation, or sales@primarahealthsciences.com for partnership inquiries. Our US-based team typically responds within one business day. Visit the contact page.
Our facilities have FDA oversight, which inspected by the FDA on a quarterly basis. We maintain a clean inspection history and are in good standing. Visit the contact page.
We have no outstanding Form 483 observations, warning letters, or unresolved corrective actions. Visit the contact page.
Yes, we operate under full cGMP compliance and can provide documentation upon request, including our cGMP certification and relevant SOPs. Visit the contact page.
Yes, we manufacture sterile injectable products in a facility validated for aseptic processing. Visit the contact page.
Yes, our API supplier is FDA compliant Visit the contact page.
Yes, a Certificate of Analysis for both the API and the finished product is provided with every batch. Visit the contact page.
Yes, every batch undergoes full testing for identity, purity, potency, sterility, endotoxin levels, and fill volume prior to release. Visit the contact page.
Yes, full batch/lot traceability is maintained and available for every unit shipped. Visit the contact page.
Beyond-use dating is assigned based on stability data and applicable USP guidelines. Visit the contact page.
Yes, private labeling is available. Visit the contact page.
Yes, subject to your applicable country/state/federal distribution regulations. Visit the contact page.
Any batch that fails third-party testing is immediately quarantined, and affected customers are notified. The batch is not released for distribution, and a full investigation and CAPA process is initiated. Visit the contact page.